With reference to the news report appearing in the Business Standard dated June 20, 2018, wherein it was stated that the mandatory open offer made by Procter & Gamble Overseas India B.V. has opened on June 13 and will close on June 26, 2018. Merck has informed that the tendering process under the open offer, as announced by Procter & Gamble Overseas India B.V. vide their public announcement dated April 19, 2018, the detailed public statement dated April 26, 2018 and the draft letter of offer dated May 7, 2018, has not yet commenced.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: